(Q43875084)

27 November 2017

Maximum a posteriori Bayesian estimation of oral cyclosporin pharmacokinetics in patients with stable renal transplants (English)

1 reference

27 November 2017

1 reference

8

Pierre Marquet

0 references

author name string

Frédéric Leger

1

1 reference

27 November 2017

Jean Debord

2

1 reference

27 November 2017

Yann Le Meur

3

1 reference

27 November 2017

Annick Rousseau

4

1 reference

27 November 2017

Mathias Büchler

5

1 reference

27 November 2017

Gérard Lachâtre

6

1 reference

27 November 2017

Gilles Paintaud

7

1 reference

27 November 2017

1 January 2002

1 reference

Clinical Pharmacokinetics

27 November 2017

1 reference

27 November 2017

41

1 reference

27 November 2017

1

1 reference

27 November 2017

71-80

1 reference

https://scigraph.springernature.com/pub.10.2165/00003088-200241010-00006

27 November 2017

0 references

cites work

Application of a gamma model of absorption to oral cyclosporin

1 reference

12 December 2020

Reduced inter- and intraindividual variability in cyclosporine pharmacokinetics from a microemulsion formulation

1 reference

12 December 2020

The relationship between cyclosporine pharmacokinetic parameters and subsequent acute rejection in renal transplant recipients

1 reference

12 December 2020

Cyclosporine monitoring in renal transplantation: area under the curve monitoring is superior to trough-level monitoring

1 reference

12 December 2020

Bayesian pharmacokinetic estimation of vinorelbine in non-small-cell lung cancer patients.

1 reference

12 December 2020

A prospective study of cyclosporine concentration in relation to its therapeutic effect and toxicity after renal transplantation

1 reference

12 December 2020

Methods for clinical monitoring of cyclosporin in transplant patients.

1 reference

12 December 2020

Optimization of cyclosporine therapy with new therapeutic drug monitoring strategies: report from the International Neoral TDM Advisory Consensus Meeting (Vancouver, November 1997).

1 reference

12 December 2020

Comparison of 2- and 3-compartment models for the Bayesian estimation of methotrexate pharmacokinetics

1 reference

12 December 2020

Lake Louise Consensus Conference on cyclosporin monitoring in organ transplantation: report of the consensus panel.

1 reference

12 December 2020

Challenges in cyclosporine therapy: the role of therapeutic monitoring by area under the curve monitoring.

1 reference

12 December 2020

Cyclosporine pharmacokinetics and variability from a microemulsion formulation--a multicenter investigation in kidney transplant patients

1 reference

12 December 2020

Some suggestions for measuring predictive performance

1 reference

12 December 2020

Impact of absorption profiling on efficacy and safety of cyclosporin therapy in transplant recipients.

1 reference

12 December 2020

Evaluation of a Bayesian approach to the pharmacokinetic interpretation of cyclosporin concentrations in renal allograft recipients.

1 reference

12 December 2020

Neoral monitoring by simplified sparse sampling area under the concentration-time curve: its relationship to acute rejection and cyclosporine nephrotoxicity early after kidney transplantation

1 reference

12 December 2020

Abbreviated pharmacokinetic profiles in area-under-the-curve monitoring of cyclosporine therapy in de novo renal transplant patients treated with Sandimmune or Neoral. Neoral study group.

1 reference

12 December 2020

Influence of cyclosporine pharmacokinetics, trough concentrations, and AUC monitoring on outcome after kidney transplantation.

1 reference

12 December 2020

Application of Bayesian forecasting to predict appropriate cyclosporine dosing regimens for renal allograft recipients

1 reference

12 December 2020

Cyclosporine monitoring in patients with renal transplants: two- or three-point methods that estimate area under the curve are superior to trough levels in predicting drug exposure.

1 reference

12 December 2020

Do cyclosporin profiles provide useful information in the management of renal transplant recipients?

1 reference

12 December 2020

Individualizing drug dosage regimens: roles of population pharmacokinetic and dynamic models, Bayesian fitting, and adaptive control

1 reference

12 December 2020

Predicting patients' exposure to cyclosporin

1 reference

12 December 2020

Optimal sampling times for pharmacokinetic experiments

1 reference

12 December 2020

10.2165/00003088-200241010-00006

Identifiers

DOI

1 reference

Dimensions Publication ID

27 November 2017

0 references

1 reference